|
| 36720081 | Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1). | | 2023 |
| 36130057 | Improving biobehavioral health in younger breast cancer survivors: Pathways to Wellness trial secondary outcomes. | Journal of the National Cancer Institute | 2023 |
| 37748973 | A pilot study of light exposure as a countermeasure for menstrual phase-dependent neurobehavioral performance impairment in women. | | 2023 |
| 37923668 | Associations of adverse childhood and lifetime experiences with sleep quality and duration among women in midlife. | | 2023 |
| 36509657 | Sleep timing, sleep regularity, and psychological health in early late life women: Findings from the Study of Women's Health Across the Nation (SWAN). | | 2023 |
| 37207451 | Effects of Sleep Fragmentation and Estradiol Decline on Cortisol in a Human Experimental Model of Menopause. | J Clin Endocrinol Metab | 2023 |
| 37496178 | Targeting psychological and menopausal factors linked to non-adherence to anti-estrogen therapy in women with early-stage hormone-receptor positive breast cancer: AÂ web-based feasibility study of Finding My Way. | | 2023 |
| 34694536 | Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN. | Breast Cancer Research and Treatment | 2022 |
| 35397292 | A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial. | Mult Scler Relat Disord | 2022 |
| 35969887 | Changes in serum endogenous estrogen concentrations are mediators of the effect of low-dose oral estradiol on vasomotor symptoms. | Menopause | 2022 |
| 35905469 | The longitudinal relation of inflammation to incidence of vasomotor symptoms. | Menopause | 2022 |
| 36099555 | Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife. | Menopause | 2022 |
| 35569055 | Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women. | J Clin Endocrinol Metab | 2022 |
| 35878624 | Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles. | Journal of Clinical Endocrinology and Metabolism | 2022 |
| 35616610 | Menopausal Hormone Therapy and the Mind: The Role of Hormone Replacement in the Prevention and Treatment of Cognitive Decline, Dementia, and Cognitive Dysfunction of Depression. | Harv Rev Psychiatry | 2022 |
| 35486944 | NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness. | Menopause | 2022 |
| 35796553 | Risk of high depressive symptoms after the final menstrual period: the Study of Women's Health Across the Nation (SWAN). | Menopause | 2022 |
| 35728741 | Preface to theme issue on women's health and clinical trials. | Contemporary Clinical Trials | 2022 |
| 36256923 | Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women's Health Across the Nation (SWAN). | Menopause | 2022 |
| 35247632 | Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019. | Contemporary Clinical Trials | 2022 |
| 35022783 | A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women. | Sleep | 2022 |
| 34954335 | Brain-derived neurotrophic factor and mood in perimenopausal depression. | J Affect Disord | 2022 |
| 34406839 | Targeting Depressive Symptoms in Younger Breast Cancer Survivors: The Pathways to Wellness Randomized Controlled Trial of Mindfulness Meditation and Survivorship Education. | Journal of Clinical Oncology | 2021 |
| 33493755 | Predictors of irritability symptoms in mildly depressed perimenopausal women. | Psychoneuroendocrinology | 2021 |
| 34081126 | Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysis. | Sleep | 2021 |
| 34016641 | Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion. | Clin Cancer Res | 2021 |
| 33906204 | A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. | Menopause | 2021 |
| 33906200 | At menopause, what comes first: the sleepless chicken or the sex? | Menopause | 2021 |
| 33583580 | What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12Â months after premenopausal risk-reducing bilateral salpingo-oophorectomy. | Gynecol Oncol | 2021 |
| 33579903 | Plasma androgens and the presence and course of depression in a large cohort of women. | Translational Psychiatry | 2021 |
| 34164605 | Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire. | JNCI Cancer Spectrum | 2021 |
| 33470142 | Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. | Journal of the American Heart Association | 2021 |
| 33832644 | Lowered progesterone metabolite excretion and a variable LH excretion pattern are associated with vasomotor symptoms but not negative mood in the early perimenopausal transition: Study of Women's Health Across the Nation. | | 2021 |
| 34095605 | Sleep and endocrine therapy in breast cancer. | Current Opinion in Endocrine and Metabolic Research | 2021 |
| 33975865 | Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study. | BMJ Open | 2021 |
| 32918659 | Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients. | Breast Cancer Research and Treatment | 2021 |
| 32918472 | Associations between sleep and cognitive performance in a racially/ethnically diverse cohort: the Study of Women's Health Across the Nation. | Sleep | 2021 |
| 33003040 | COVID-19 Threatens Progress Toward Gender Equity Within Academic Medicine. | Academic Medicine | 2021 |
| 33410460 | Longitudinal Association Between Depressive Symptoms and Multidimensional Sleep Health: The SWAN Sleep Study. | Ann Behav Med | 2021 |
| 33323762 | Hypothalamic-pituitary-adrenal axis, subjective, and thermal stress responses in midlife women with vasomotor symptoms. | Menopause | 2020 |
| 31965189 | Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. | J Clin Endocrinol Metab | 2020 |
| 31693131 | Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms. | J Clin Endocrinol Metab | 2020 |
| 32068688 | Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial. | Menopause | 2020 |
| 31633180 | Does midlife aging impact women's sleep duration, continuity, and timing?: A longitudinal analysis from the Study of Women's Health Across the Nation. | Sleep | 2020 |
| 31577333 | Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women. | JAMA Psychiatry | 2020 |
| 31934947 | Trajectory analysis of sleep maintenance problems in midlife women before and after surgical menopause: the Study of Women's Health Across the Nation (SWAN). | Menopause | 2020 |
| 32040165 | Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review. | JAMA Internal Medicine | 2020 |
| 32384135 | Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us. | Annals of Internal Medicine | 2020 |
| 31977667 | Lights on MsFLASH: a review of contributions. | Menopause | 2020 |
| 32459749 | Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling. | Menopause | 2020 |